TickerGuard
Buy Day today: Poor (52) Mixed market breadth · today: Core PCE (August) ≈
NTRA

Natera Inc

Healthcare · Diagnostics & Research

408.80$ +4.6% vs. previous close Closing price · As of: Sep 24, 2026

Statements

Cash Flow

All figures as a percentage of revenue in the same period.

Tick rows to compare them in a chart (up to 4)

Cash Flow NTRA
Line item 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
-104.6% -43.7% 6.6% -19.9% -34.1% -46.4% -27.4% -21.0% -46.7% -53.6% -52.6% -22.8% 8.0% 9.3%
5.1% 4.6% 3.2% 2.9% 2.8% 3.4% 2.9% 2.6% 2.2% 1.8% 2.0% 2.2% 1.8% 1.9%
4.2% 3.0% 3.2% 3.8% 4.9% 5.4% 5.5% 9.5% 12.8% 18.4% 18.6% 17.7% 16.2% 15.4%
– – 4.4% 9.6% 7.3% 5.5% 7.8% 5.7% 14.6% 24.2% 20.0% – – –
-11.0% -3.2% 2.2% 4.9% 1.1% 9.3% 10.5% 9.0% -10.0% -7.3% -10.1% -4.4% 0.1% 0.4%
32.2% 14.9% 6.3% 4.1% 10.7% 4.7% 1.5% 1.6% 5.0% 6.6% 5.8% 3.6% 3.9% 4.6%
-32.2% -14.9% -6.2% -110.7% 21.7% 6.5% -2.0% -88.1% -84.8% -32.8% 40.3% 15.6% 8.1% -5.7%
– – – 0.0% 1.2% 0.0% – – 1.8% – 3.7% – – –
-0.2% – 0.1% 95.2% 1.2% 1.6% 1.4% 1.4% 1.8% 2.2% 1.6% 1.4% 1.0% –
– – 1.6% 4.6% 3.2% 35.4% 77.5% 66.0% 51.0% 4.8% 3.7% 0.0% 0.0% 0.0%
0.4% 103.5% 35.2% 100.0% 6.1% 38.1% 44.1% 112.7% 128.1% 92.1% 58.8% 23.5% 1.8% 2.1%
-136.4% 44.9% 35.6% -30.6% -6.4% -1.7% 14.7% 3.6% -3.4% 5.7% 46.5% 16.3% 17.9% 5.7%
-136.8% -58.7% 0.3% -24.0% -44.7% -50.6% -28.9% -22.6% -51.7% -60.2% -58.4% -26.4% 4.1% 4.7%

Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?